Advanced imaging (positron emission tomography and magnetic resonance imaging) and image-guided biopsy in initial staging and monitoring of therapy of lung cancer

Shaheen Islam, Ronald C. Walker

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

The results of the National Lung Screening Trial strongly support early detection and definitive treatment to reduce lung cancer mortality. Once lung cancer is discovered, accurate staging at baseline is imperative to maximize patient benefit and cost-effective use of health care resources. Although computed tomography (CT) remains a powerful tool for staging of lung cancer, advances in other imaging modalities, specifically positron emission tomography/CT and magnetic resonance imaging, can improve baseline staging over CT alone and can allow a more rapid and accurate assessment of response to treatment. Although noninvasive imaging is extremely useful, tissue diagnosis remains the criterion standard for staging lung cancer and monitoring treatment response. Accordingly, tissue sampling using advanced bronchoscopic imaging guidance, such as ultrasound or electromagnetic navigation, allows precise tissue location and sampling of mediastinal nodes or lung nodules in the least invasive manner. In the future, bronchoscopy may allow real-time microscopic analysis.

Original languageEnglish (US)
Pages (from-to)208-216
Number of pages9
JournalCancer Journal (United States)
Volume19
Issue number3
DOIs
StatePublished - May 1 2013

Fingerprint

Image-Guided Biopsy
Positron-Emission Tomography
Lung Neoplasms
Magnetic Resonance Imaging
Tomography
Lung
Health Resources
Electromagnetic Phenomena
Bronchoscopy
Therapeutics
Cost-Benefit Analysis
Delivery of Health Care
Mortality

Keywords

  • Bronchoscopic imaging
  • Confocal bronchoscopy
  • EBUS
  • Image-guided biopsy
  • Lung cancer
  • Lung cancer staging
  • MRI
  • Navigation bronchoscopy
  • PET

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{5757d55f59a64a028ebda47e93e9d28c,
title = "Advanced imaging (positron emission tomography and magnetic resonance imaging) and image-guided biopsy in initial staging and monitoring of therapy of lung cancer",
abstract = "The results of the National Lung Screening Trial strongly support early detection and definitive treatment to reduce lung cancer mortality. Once lung cancer is discovered, accurate staging at baseline is imperative to maximize patient benefit and cost-effective use of health care resources. Although computed tomography (CT) remains a powerful tool for staging of lung cancer, advances in other imaging modalities, specifically positron emission tomography/CT and magnetic resonance imaging, can improve baseline staging over CT alone and can allow a more rapid and accurate assessment of response to treatment. Although noninvasive imaging is extremely useful, tissue diagnosis remains the criterion standard for staging lung cancer and monitoring treatment response. Accordingly, tissue sampling using advanced bronchoscopic imaging guidance, such as ultrasound or electromagnetic navigation, allows precise tissue location and sampling of mediastinal nodes or lung nodules in the least invasive manner. In the future, bronchoscopy may allow real-time microscopic analysis.",
keywords = "Bronchoscopic imaging, Confocal bronchoscopy, EBUS, Image-guided biopsy, Lung cancer, Lung cancer staging, MRI, Navigation bronchoscopy, PET",
author = "Shaheen Islam and Walker, {Ronald C.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1097/PPO.0b013e318295185f",
language = "English (US)",
volume = "19",
pages = "208--216",
journal = "Cancer Journal",
issn = "1528-9117",
number = "3",

}

TY - JOUR

T1 - Advanced imaging (positron emission tomography and magnetic resonance imaging) and image-guided biopsy in initial staging and monitoring of therapy of lung cancer

AU - Islam, Shaheen

AU - Walker, Ronald C.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - The results of the National Lung Screening Trial strongly support early detection and definitive treatment to reduce lung cancer mortality. Once lung cancer is discovered, accurate staging at baseline is imperative to maximize patient benefit and cost-effective use of health care resources. Although computed tomography (CT) remains a powerful tool for staging of lung cancer, advances in other imaging modalities, specifically positron emission tomography/CT and magnetic resonance imaging, can improve baseline staging over CT alone and can allow a more rapid and accurate assessment of response to treatment. Although noninvasive imaging is extremely useful, tissue diagnosis remains the criterion standard for staging lung cancer and monitoring treatment response. Accordingly, tissue sampling using advanced bronchoscopic imaging guidance, such as ultrasound or electromagnetic navigation, allows precise tissue location and sampling of mediastinal nodes or lung nodules in the least invasive manner. In the future, bronchoscopy may allow real-time microscopic analysis.

AB - The results of the National Lung Screening Trial strongly support early detection and definitive treatment to reduce lung cancer mortality. Once lung cancer is discovered, accurate staging at baseline is imperative to maximize patient benefit and cost-effective use of health care resources. Although computed tomography (CT) remains a powerful tool for staging of lung cancer, advances in other imaging modalities, specifically positron emission tomography/CT and magnetic resonance imaging, can improve baseline staging over CT alone and can allow a more rapid and accurate assessment of response to treatment. Although noninvasive imaging is extremely useful, tissue diagnosis remains the criterion standard for staging lung cancer and monitoring treatment response. Accordingly, tissue sampling using advanced bronchoscopic imaging guidance, such as ultrasound or electromagnetic navigation, allows precise tissue location and sampling of mediastinal nodes or lung nodules in the least invasive manner. In the future, bronchoscopy may allow real-time microscopic analysis.

KW - Bronchoscopic imaging

KW - Confocal bronchoscopy

KW - EBUS

KW - Image-guided biopsy

KW - Lung cancer

KW - Lung cancer staging

KW - MRI

KW - Navigation bronchoscopy

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=84880108810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880108810&partnerID=8YFLogxK

U2 - 10.1097/PPO.0b013e318295185f

DO - 10.1097/PPO.0b013e318295185f

M3 - Review article

VL - 19

SP - 208

EP - 216

JO - Cancer Journal

JF - Cancer Journal

SN - 1528-9117

IS - 3

ER -